Corvus Pharmaceuticals (CRVS) Stock: Buy, Sell, or Hold?
$10.62
-0.85 (-7.41%)
âŧ
5d:
+9.15%
30d:
+13.22%
90d:
-28.68%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect CRVS Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (44%)
Quality Score
40/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$9.76 â $10.84
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-9.7x
Next 12M consensus est.
Wall Street Target
$31.50
+196.6% upside
Options IV & Volume
36th pct IV
HIGH volume confirmation
Support / Resistance
$9.58 / $11.78
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CRVS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 5, 2026 at $10.48 · last confirmed Nov 9, 2026
Strength: 8.4/10
Get Alerted When CRVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRVS is currently trading at $10.62, which is considered slightly high relative to its 30-day fair value range of $9.76 to $10.84.
Technical Outlook: Technically, CRVS is in a strong downtrend. Immediate support is located at $9.58, while resistance sits at $11.78. Short-term momentum is weak, with the stock down 7.4% recently.
Market Sentiment: CRVS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.50 (+196.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRVS is in a strong downtrend. Immediate support is located at $9.58, while resistance sits at $11.78. Short-term momentum is weak, with the stock down 7.4% recently.
Market Sentiment: CRVS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.50 (+196.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$9.76 -
$10.84
Company Quality Score
40/100
(HOLD)
Options IV Signal
36th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
43.8%
Trading Range & Key Levels
30-Day Trading Range
$9.76 -
$10.84
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$1.30
(12.2%)
Support Level
$9.58
Resistance Level
$11.78
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding CRVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Options fairly priced (IV 36th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.4%)
- BULLISH: Trading 196.6% below Wall St target ($31.50)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-9.65
Wall Street Target
$31.50
(+196.6%)
Share CRVS Analysis
Share this live CRVS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRVS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment towards $CRVS, with one user praising Miller's leadership as resembling a research lab with no commercial consequences.
Key Retail Themes:
Bullish sentiment towards $CRVS leadership
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:23 AM ET
Data refreshes hourly during market hours. Next update: 6:23 AM
Data refreshes hourly during market hours. Next update: 6:23 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$592 | 39 SELL |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
IDYA
Ideaya Biosciences Inc |
STRONG BUY
16 analysts |
$51 | 60 BUY |
Advanced CRVS Option Strategies
Professional options setups generated by AI based on today's CRVS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRVS Research Pages
